Prothrombin Complex Concentrates are Superior to Fresh Frozen Plasma for Emergency Reversal of Vitamin K Antagonists: A Meta-Analysis in 2606 Subjects

被引:14
作者
Hill, Robert [1 ]
Han, Thang S. [2 ]
Lubomirova, Irina [1 ]
Math, Nikhil [1 ]
Bentley, Paul [1 ]
Sharma, Pankaj [1 ,2 ]
机构
[1] Imperial Coll London, Imperial Coll Healthcare NHS Trust, Dept Med, London SW7 2AZ, England
[2] Royal Holloway Univ London ICR2UL, Inst Cardiovasc Res, Egham TW20 0EX, Surrey, England
关键词
WARFARIN REVERSAL; INTRACEREBRAL HEMORRHAGE; ANTICOAGULANT-THERAPY; GUIDELINES; MANAGEMENT; COAGULOPATHY; STRATEGIES; EFFICACY; OUTCOMES;
D O I
10.1007/s40265-019-01179-w
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Urgent reversal of vitamin K antagonists (VKAs) is required for major bleeding or urgent surgery by intravenous vitamin K with either prothrombin complex concentrates (PCCs) or fresh frozen plasma (FFP). However, there is lack of consensus regarding the superiority of either reversal agent. We sought to compare the performance of PCC and FFP in urgent reversal of VKA. Methods A meta-analysis was conducted up to November 2018. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a random effects model. Results Seventeen studies comprising 2606 participants met the inclusion criteria. Compared with FFP treatment, PCC treatment led to a reduction in 90-day all-cause mortality (OR 0.60, 95% CI 0.40-0.90, p = 0.01), better reversal of INR (OR 7.36, 95% CI 4.18-12.98; p < 0.00001) and lower risk of at least one treatment-related adverse event (OR 0.45, 95% CI 0.26-0.80, p = 0.006). Among patients with VKA-associated intracranial haemorrhage, PCC treatment led to a reduction in 90-day all-cause mortality (OR 0.58, 95% CI 0.35-0.94, p = 0.03) and better reversal of INR (OR 6.52, 95% CI 1.66-25.59, p = 0.007). There were no differences between these two agents in thrombogenicity, requirement for and quantity of red blood cell transfusions, all adverse events, fluid overload or disability on discharge or at 90 days. Conclusions As an agent for urgent reversal of VKA, PCC outperforms FFP in 90-day all-cause mortality including those with VKA-related intracranial haemorrhage, INR reversal and treatment-related adverse events.
引用
收藏
页码:1557 / 1565
页数:9
相关论文
共 50 条
[41]   Uninterrupted New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Ablation of Atrial Fibrillation: A Meta-analysis [J].
Nairooz, Ramez ;
Ayoub, Karam ;
Sardar, Partha ;
Payne, Jason ;
Almomani, Ahmed ;
Pothineni, Naga Venkata ;
Shailesh, Fnu ;
Aronow, Wilbert S. ;
Mukherjee, Debabrata .
CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (06) :814-823
[42]   Non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta-analysis of observational studies [J].
Guo, Zongwen ;
Ding, Xiaoli ;
Ye, Zi ;
Chen, Weiling ;
Chen, Yijian .
CLINICAL CARDIOLOGY, 2021, 44 (07) :917-924
[43]   Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis [J].
Boulouis, Gregoire ;
Morotti, Andrea ;
Pasi, Marco ;
Goldstein, Joshua N. ;
Gurol, M. Edip ;
Charidimou, Andreas .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (03) :263-270
[44]   Direct oral anticoagulants or vitamin K antagonists after TAVR: A systematic review and meta-analysis [J].
Oliveri, Federico ;
Montalto, Claudio ;
Tua, Lorenzo ;
Lanzillo, Giuseppe ;
Compagnoni, Sara ;
Fasolino, Alessandro ;
Gentile, Francesca Romana ;
Ferlini, Marco ;
Pepe, Antonella ;
Visconti, Luigi Oltrona ;
Bongiorno, Andrea ;
Leonardi, Sergio .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 365 :123-130
[45]   A Meta-Analysis of Randomized Controlled Trials of the Risk of Bleeding With Apixaban Versus Vitamin K Antagonists [J].
Touma, Lahoud ;
Filion, Kristian B. ;
Atallah, Renee ;
Eberg, Maria ;
Eisenberg, Mark J. .
AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (04) :533-541
[46]   Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registries [J].
Rivera-Caravaca, Jose Miguel ;
Menichelli, Danilo ;
Pastori, Daniele ;
Soler-Espejo, Eva ;
Esteve-Pastor, Maria Asuncion ;
Vivas, David ;
Roldan, Inmaculada ;
Anguita, Manuel ;
Ferreiro, Jose Luis ;
Roldan, Vanessa ;
Marin, Francisco .
MEDICINA CLINICA, 2025, 165 (03)
[47]   Therapeutic efficacy of direct oral anticoagulants and vitamin K antagonists for left ventricular thrombus: Systematic review and meta-analysis [J].
Kitano, Tetsuji ;
Nabeshima, Yosuke ;
Kataoka, Masaharu ;
Takeuchi, Masaaki .
PLOS ONE, 2021, 16 (07)
[48]   Efficacy of the prothrombin complex concentrate prothromplex in patients requiring urgent reversal of vitamin K antagonists or presenting with uncontrolled bleeding: a retrospective, single center study [J].
Leal-Noval, Santiago R. ;
Lopez-Irizo, Rosa ;
Bautista-Paloma, Javier ;
Casado, Manuel ;
Arellano-Orden, Victoria ;
Leal-Romero, Maria ;
Fernandez-Hinojosa, Esteban ;
Puppo-Moreno, Antonio ;
Munoz, Manuel .
BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (08) :862-868
[49]   Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal [J].
Refaai, Majed A. ;
Goldstein, Joshua N. ;
Lee, Martin L. ;
Durn, Billie L. ;
Milling, Truman J., Jr. ;
Sarode, Ravi ;
Kovaleski, Kevin .
TRANSFUSION, 2015, 55 (11) :2722-2729
[50]   Meta-Analysis Comparing the Effect of Rivaroxaban Versus Vitamin K Antagonists for Treatment of Left Ventricular Thrombi [J].
Saleh, Yehia ;
Al-Abcha, Abdullah ;
Abdelkarim, Ola ;
Elwany, Mostafa ;
Abdelfattah, Omar M. ;
Abdelnabi, Mahmoud ;
Almaghraby, Abdallah .
AMERICAN JOURNAL OF CARDIOLOGY, 2021, 161 :123-125